Loading...
•
Mar 31, 2024
GE HealthCare Q1 2024 Earnings Report
GE HealthCare's financial performance in Q1 2024 showed a slight revenue decline but margin expansion, driven by productivity and pricing. The company reaffirmed its full-year guidance.
Key Takeaways
GE HealthCare reported a 1% decline in revenues, but organic revenue was approximately flat. Net income margin increased to 8.0%, and adjusted EBIT margin rose to 14.7%. Diluted EPS was $0.81, and adjusted EPS was $0.90. The company reaffirmed its full-year 2024 guidance.
Revenues declined 1% year-over-year, but organic revenue growth was approximately flat.
Net income margin increased to 8.0%, and adjusted EBIT margin rose to 14.7%.
Diluted EPS was $0.81, and adjusted EPS was $0.90.
Cash flow from operating activities was $419 million, and free cash flow was $274 million. Company reaffirmed full year 2024 guidance
Revenue by Segment
Forward Guidance
The Company is reaffirming full year 2024 guidance as follows:
Positive Outlook
- Organic revenue growth of approximately 4% year-over-year.
- Adjusted EBIT margin in the range of 15.6% to 15.9%, reflecting an expansion of 50 to 80 basis points versus 2023 Adjusted EBIT margin of 15.1%.
- Adjusted effective tax rate (ETR) in the range of 23% to 25%.
- Adjusted EPS in the range of $4.20 to $4.35, representing 7% to 11% growth versus Adjusted EPS of $3.93 for 2023.
- Free cash flow of approximately $1.8 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...